Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decision aids for female BRCA mutation carriers: a scoping review.

BMJ open - 13 Jun 2024

McGarrigle Sarah A, Prizeman Geraldine, Spillane Carol, Byrne Niamh, Drury Amanda, Polus Manria, Mockler David, Connolly Elizabeth M, Brady Anne-Marie, Hanhauser Yvonne P

Abstract excerpt

OBJECTIVES: Women who inherit a pathogenic BRCA1 or BRCA2 mutation are at substantially higher risk of developing breast and ovarian cancer than average. Several cancer risk management strategies exist to address this increased risk. Decisions about which strategies to choose are complex, personal and multifactorial for these women. Decision aids (DAs) are tools that assist patients in making health-related...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Decision Making

Share to Decision Support Techniques

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38871662
DOI: 10.1136/bmjopen-2023-076876
PMCID: PMC11177699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decision aids for female BRCA mutation carriers: a scoping review.PMID 38871662Read ↗

Decision aids for female BRCA mutation carriers: a scoping review protocol.Semantic proximity Read ↗

Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation.Semantic proximity Read ↗

The clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.Semantic proximity Read ↗

Clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence Variations.Semantic proximity Read ↗

Risk management decisions in women with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Risk Assessment, Genetic Counseling, and Genetic Testing forBRCA-Related Cancer in WomenSemantic proximity Read ↗

Management options after prophylactic surgeries in women with BRCA mutations: a review.Semantic proximity Read ↗

Discussion of "Risk management decisions in women with BRCA1 and BRCA2 mutations".Semantic proximity Read ↗

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.